Switzer TV

 

In our last episode of 2025, we get the heavy hitters. This week on Switzer Investing TV, Peter Switzer sits down with three seasoned market pros to cut through the noise and talk straight about where the real growth opportunities may lie heading into 2026.

With tech stocks sold off, resources rotating back into favour, and AI fears dominating headlines, each guest lays out what they’d actually buy now and why.

Adam Dawes kicks things off by explaining why selective commodities, developers and beaten-up growth names are back on the radar, and where investors need to be careful.

Jun Bei Liu then shares her “buy low” Christmas gift ideas, focusing on high-quality growth companies that have fallen out of favour but continue to grow earnings. Finally, Paul Rickard wraps up the year with a pragmatic take on oversold tech, patience, and which names could reward investors willing to look past short-term fear.

Interview timecodes:

00:01:01 - Adam Dawes, Shaw and Partners

00:17:41 - Jun Bei Liu, TenCap

00:25:37 - Paul Rickard, Switzer Report

 

This is our last show for 2025. We thank you for joining us and we'll see you on 10 January, 2026 with a new year of Switzer Investing TV.

Switzer Investing TV (15/12/25): What would our experts invest in now for growth in 2026?

In our last episode of 2025, we get the heavy hitters. This week on Switzer Investing TV, Peter Switzer sits down with three seasoned market pros to cut through the noise and talk straight about where the real growth opportunities may lie heading into 2026.

More videos

Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the big money stories and how they affect you in our final Mad about Money of the year.

Series: ,
2 top fund managers rate Appen, Xero, Nuix & Zip: To Buy or Not to Buy?!

On this week's show, Burman Invest's Julia Lee, Tribeca Investment Partners' Jun Bei Liu and Switzer's Paul Rickard join Peter Switzer.

Series: ,
Should you take a multivitamin every day?

Dr Ross Walker discusses the longest-running trial in relation to multivitamins and the potential benefits of long-term multivitamin use.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money news and how it affects you.

Series: ,
Bevan Slattery explains Megaport & Is Treasury Wine Estates in the buying zone?

In this week's show, Peter Switzer speaks to Adam Dawes, Bevan Slattery, Julia Lee, Paul Rickard, Ying Yi Ann Cheng and Michael Gable.

Series: ,
Do multivitamins work?

Dr Ross Walker points out some issues with recent studies that have suggested multivitamins do nothing.

Series: ,
Could the bad bully boys of Beijing hurt our stock market + Paul’s got 2 stocks to sell & 2 to buy!

Join Peter Switzer and Paul Rickard for the latest episode of Mad about Money.

Series: ,
Have the Beijing bad boys turned Treasury Wine Estates and a2 milk into screaming buys?!

On this week's investing show, Peter Switzer is joined by Julia Lee from Burman Invest, Rudi Filapek-VanDyck from FNArena, Jun Bei Liu from Tribeca Investment Partners and Paul Rickard.

Series: ,
New COVID-19 evidence

Dr Ross Walker talks about new evidence of the coronavirus, its fatality rates and possible mutations.

Series: ,
Is ScoMo starting to suck up to the Beijing bad boys & what 2 stocks could benefit?

Join Peter Switzer and Paul Rickard for the latest episode of Mad about Money.

Series: ,
Why is Mesoblast blasting higher again & 3 new stocks that are hot!

On this week's show, Peter Switzer speaks to Shaw and Partners' Adam Dawes, Burman Invest's Julia Lee, AMP Capital's Shane Oliver, Switzer's Paul Rickard and nabtrade's Gemma Dale.

Series: ,
The Oxford COVID-19 vaccine trial

Dr Ross Walker looks at the differences between the Oxford and Pfizer vaccine trials and shares the promising results from both.

Series: ,
1 37 38 39 40 41 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram